Ristopime-T Injection

Ristopime-T Injection is a sterile combination of Cefepime and Tazobactam formulated for the treatment of moderate to severe bacterial infections. Cefepime provides broad-spectrum antibacterial activity, while Tazobactam enhances its effectiveness by inhibiting beta-lactamase enzymes produced by resistant bacteria. It is indicated for infections of the respiratory tract, urinary tract, skin and soft tissues, intra-abdominal region, bloodstream, and other susceptible bacterial infections. Suitable for I.V. and I.M. administration, Ristopime-T Injection should be administered only under the supervision of a qualified healthcare professional.

Category:

Description

Cefepime & Tazobactam for Injection

Ristopime-T Injection is a sterile combination of Cefepime and Tazobactam formulated for intravenous (I.V.) and intramuscular (I.M.) administration. Cefepime is a fourth-generation cephalosporin antibiotic with broad-spectrum activity against a wide range of Gram-positive and Gram-negative bacteria. Tazobactam is a beta-lactamase inhibitor that protects Cefepime from enzymatic degradation by beta-lactamase-producing bacteria, enhancing its antibacterial effectiveness against resistant organisms.

This advanced antibiotic combination is used in the treatment of susceptible bacterial infections involving the respiratory tract, urinary tract, skin and soft tissues, intra-abdominal infections, bloodstream infections, and febrile neutropenia. The formulation provides reliable antimicrobial coverage and is intended for use under the supervision of a qualified healthcare professional.

Key Benefits

  • Broad-spectrum antibacterial activity against susceptible Gram-positive and Gram-negative bacteria.
  • Enhanced efficacy against beta-lactamase-producing organisms.
  • Helps manage moderate to severe bacterial infections.
  • Suitable for intravenous and intramuscular administration.
  • Sterile injectable formulation for rapid systemic action.
  • Appropriate for pediatric and adult patients as prescribed.
  • Supports effective infection management in hospital and clinical settings.

Composition

Each vial contains:

  • Cefepime IP equivalent to 250 mg
  • Tazobactam Sodium IP equivalent to 31.25 mg

(Total strength: 281.25 mg)

Indications

Recommended for the treatment of susceptible bacterial infections, including:

  • Lower and upper respiratory tract infections
  • Urinary tract infections
  • Skin and soft tissue infections
  • Intra-abdominal infections
  • Bloodstream infections (Septicemia)
  • Febrile neutropenia
  • Complicated bacterial infections requiring broad-spectrum antibiotic therapy

Directions for Use

Reconstitute with the recommended diluent before administration. Administer only by intravenous (I.V.) or intramuscular (I.M.) route under the supervision of a qualified healthcare professional. Dosage and duration should be determined by the treating physician based on the patient’s age, body weight, severity of infection, and renal function.

Storage

  • Store below 25°C in a cool and dry place.
  • Protect from light and moisture.
  • Use the reconstituted solution within the recommended time.
  • Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “Ristopime-T Injection”

Your email address will not be published. Required fields are marked *